Trump health officials signal eased FDA rules for rare disease gene therapy, but concerns linger over safety, oversight, and ...

President Trump's 2026 budget proposes cutting NIH grants to universities, academic medical centers, and other institutions ...

Omada Health, a 14-year-old digital health company supporting chronic disease patients, has yet to generate profits.

A large government study published Thursday shows more definitively than ever before that Americans’ self-reported race is a ...

RFK Jr.'s admission raises new concerns about a possible upcoming wave of reckless stem cell deregulation from this ...

From 2020 to 2024, universities contributed patents underpinning 50% of FDA-approved drugs. 87% of those academic ...

An internal document reveals how UnitedHealth Group's leadership prepared to downplay complaints about its business practices ...

The NIH archives of the Human Genome Project could fall victim to Trump administration cuts, writes a former archivist.

Novo Nordisk’s stock has tumbled over 50% since its peak around a year ago, and it just ousted its CEO. Former employees say ...

It looks like the NIH is thinking about AI differently than the FDA, who earlier this week released a “rushed” AI tool across ...

While overall risk of macular degeneration remained low, a study suggests that GLP-1 drugs may have increased that risk in ...

The rewriting of government recommendations will make the effort to get vaccine doses into arms exponentially more difficult, ...